Oncology Pharma Inc. (ONPH)
OTCMKTS · Delayed Price · Currency is USD
0.0650
+0.0001 (0.15%)
At close: Sep 9, 2026
Oncology Pharma Market Cap
Oncology Pharma has a market cap or net worth of $2.51 million as of September 10, 2026. Its market cap has increased by 64,905.41% in one year.
Market Cap
2.51M
Enterprise Value
n/a
Revenue
10.21K
Ranking
n/a
PE Ratio
13.51
Stock Price
$0.07
ChartMarket Cap Chart
Since April 1, 2016, Oncology Pharma's market cap has increased from 27.10K to 2.51M, an increase of 9,173.46%. That is a compound annual growth rate of 54.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2026 | 2.51M | 1,525.00% |
| Dec 31, 2025 | 154.65K | 3,900.34% |
| Dec 31, 2024 | 3.87K | -50.01% |
| Dec 29, 2023 | 7.73K | -99.94% |
| Dec 30, 2022 | 13.06M | -90.45% |
| Dec 31, 2021 | 136.74M | 1,159.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Wright Investors' Service Holdings | 3.51M |
| Enterra | 3.22M |
| Blue Star Global | 3.16M |
| ZhongMin Mei-Hao Holding Co | 3.00M |
| Golden Valley Development | 2.94M |
| Affiliated Resources | 2.91M |
| Atlantica | 2.46M |
| Aimrite Holdings | 2.39M |